Treatment of Peyronie's disease with hyperthermia, vitamin D and testosterone: a pilot randomised controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN82950322

Enrollment

Registered

2007-10-30

Start date

2010-04-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peyronie's disease Urological and Genital Diseases Peyronie's disease

Interventions

Please note that as of 06/02/2008 the anticipated end date of this trial was extended to 26/03/2010. The previous anticipated end date was 26/09/2008. Current interventions as of 25/02/2010: The int

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Patients with Peyronie's disease.

Exclusion criteria

Exclusion criteria: 1. Prostate cancer 2. Hyperprolactinaemia 3. Congestive heart failure 4. Severe dyslipidemia 5. Severe hypertension

Design outcomes

Primary

Measure	Time frame
1. Decreased size of plaques, measured every month throughout the duration of the trial 2. Decreased curvature of penis, measured every month throughout the duration of the trial	—

Secondary

Measure	Time frame
1. Improvement of sexual function, measured every month throughout the duration of the trial 2. Improvement of self-esteem, measured every month throughout the duration of the trial	—

Countries

Brazil

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026